{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:01:20Z","timestamp":1793703680319,"version":"4.5.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T00:00:00Z","timestamp":1456099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Yonsei University Future-leading Research Initiative of 2014","award":["Yonsei University Future-leading Research Initiative of 2014"],"award-info":[{"award-number":["Yonsei University Future-leading Research Initiative of 2014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12072-016-9705-x","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T11:54:23Z","timestamp":1456142063000},"page":"819-828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Renin\u2013angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review"],"prefix":"10.1007","volume":"10","author":[{"given":"Gaeun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Li","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Koo","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"key":"9705_CR1","doi-asserted-by":"crossref","unstructured":"Moreno M, Gonzalo T, Kok RJ, et al. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology 2010;51(3):942\u2013952","DOI":"10.1002\/hep.23419"},{"key":"9705_CR2","doi-asserted-by":"crossref","unstructured":"Eom YW, Shim KY, Baik SK. Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med 2015;30(5):580\u2013589","DOI":"10.3904\/kjim.2015.30.5.580"},{"key":"9705_CR3","doi-asserted-by":"publisher","unstructured":"Kim G, Lee SS, Baik SK, et al. The need for histological subclassification of cirrhosis: a systematic review and meta-analysis. Liver Int 2015. doi: 10.1111\/liv.12923 . [Epub ahead of print]","DOI":"10.1111\/liv.12923"},{"key":"9705_CR4","doi-asserted-by":"crossref","unstructured":"Kim G, Cho YZ, Baik SK. Assessment for risk of bias in systematic reviews and meta-analyses in the field of hepatology. Gut Liver 2015;9(6):701\u2013706","DOI":"10.5009\/gnl14451"},{"key":"9705_CR5","doi-asserted-by":"crossref","unstructured":"Kim G, Eom YW, Baik SK, et al. Therapeutic effects of mesenchymal stem cells for patients with chronic liver diseases: systematic review and meta-analysis. J Korean Med Sci 2015;30(10):1405\u20131415","DOI":"10.3346\/jkms.2015.30.10.1405"},{"key":"9705_CR6","doi-asserted-by":"crossref","unstructured":"Kim G, Cho YZ, Baik SK, Kim MY, Hong WK, Kwon SO. The accuracy of ultrasonography for the evaluation of portal hypertension in patients with cirrhosis: a systematic review. Korean J Radiol 2015;16(2):314\u2013324","DOI":"10.3348\/kjr.2015.16.2.314"},{"key":"9705_CR7","doi-asserted-by":"crossref","unstructured":"Kim G, Baik SK. Overview and recent trends of systematic reviews and meta-analyses in hepatology. Clin Mol Hepatol 2014;20(2):137\u2013150","DOI":"10.3350\/cmh.2014.20.2.137"},{"key":"9705_CR8","doi-asserted-by":"crossref","unstructured":"Hong WK, Shim KY, Baik SK, et al. Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease. J Korean Med Sci 2014;29(3):392\u2013399","DOI":"10.3346\/jkms.2014.29.3.392"},{"key":"9705_CR9","doi-asserted-by":"crossref","unstructured":"Kim MY, Baik SK, Park DH, et al. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. J Gastroenterol 2008;43(11):889\u2013896","DOI":"10.1007\/s00535-008-2239-9"},{"key":"9705_CR10","doi-asserted-by":"crossref","unstructured":"Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol 2005;3(2):95\u2013107","DOI":"10.1016\/S1542-3565(04)00445-8"},{"key":"9705_CR11","doi-asserted-by":"crossref","unstructured":"Pereira RM, dos Santos RA, da Costa Dias FL, Teixeira MM, Simoes e Silva AC. Renin-angiotensin system in the pathogenesis of liver fibrosis. World J Gastroenterol 2009;15(21):2579\u20132586","DOI":"10.3748\/wjg.15.2579"},{"key":"9705_CR12","doi-asserted-by":"crossref","unstructured":"Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005;289(6):H2281\u2013H2290","DOI":"10.1152\/ajpheart.00618.2005"},{"key":"9705_CR13","doi-asserted-by":"crossref","unstructured":"Kim JH, Kim JM, Cho YZ, et al. Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension. Clin Mol Hepatol 2014;20(4):376\u2013383","DOI":"10.3350\/cmh.2014.20.4.376"},{"key":"9705_CR14","doi-asserted-by":"crossref","unstructured":"Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003;35(6):881\u2013900","DOI":"10.1016\/S1357-2725(02)00271-6"},{"key":"9705_CR15","doi-asserted-by":"crossref","unstructured":"Munshi MK, Uddin MN, Glaser SS. The role of the renin\u2013angiotensin system in liver fibrosis. Exp Biol Med (Maywood) 2011;236(5):557\u2013566","DOI":"10.1258\/ebm.2011.010375"},{"key":"9705_CR16","doi-asserted-by":"crossref","unstructured":"Tox U, Steffen HM. Impact of inhibitors of the renin\u2013angiotensin\u2013aldosterone system on liver fibrosis and portal hypertension. Curr Med Chem 2006;13(30):3649\u20133661","DOI":"10.2174\/092986706779026138"},{"key":"9705_CR17","doi-asserted-by":"crossref","unstructured":"Tandon P, Abraldes JG, Berzigotti A, Garcia-Pagan JC, Bosch J. Renin\u2013angiotensin\u2013aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis. J Hepatol 2010;53(2):273\u2013282","DOI":"10.1016\/j.jhep.2010.03.013"},{"key":"9705_CR18","doi-asserted-by":"crossref","unstructured":"Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014;20(15):4300\u20134315","DOI":"10.3748\/wjg.v20.i15.4300"},{"key":"9705_CR19","unstructured":"Mohamadnejad M, Tavangar SM, Sotoudeh M, et al. Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems. Int J Organ Transplant Med 2010;1(4):171\u2013176"},{"key":"9705_CR20","doi-asserted-by":"crossref","unstructured":"Abu Dayyeh BK, Yang M, Dienstag JL, Chung RT. The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort. Dig Dis Sci 2011;56(2):564\u2013568","DOI":"10.1007\/s10620-010-1507-8"},{"key":"9705_CR21","doi-asserted-by":"crossref","unstructured":"Corey KE, Shah N, Misdraji J, et al. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int 2009;29(5):748\u2013753","DOI":"10.1111\/j.1478-3231.2009.01973.x"},{"key":"9705_CR22","doi-asserted-by":"crossref","unstructured":"Guillaud O, Gurram KC, Puglia M, et al. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation. Transplant Proc 2013;45(6):2331\u20132336","DOI":"10.1016\/j.transproceed.2013.01.067"},{"key":"9705_CR23","doi-asserted-by":"crossref","unstructured":"Kim MY, Cho MY, Baik SK, et al. Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis\u2014a randomized open-label controlled study. Liver Int 2012;32(6):977\u2013987","DOI":"10.1111\/j.1478-3231.2012.02774.x"},{"key":"9705_CR24","doi-asserted-by":"crossref","unstructured":"Rimola A, Londono MC, Guevara G, et al. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation. Transplantation 2004;78(5):686\u2013691","DOI":"10.1097\/01.TP.0000128913.09774.CE"},{"key":"9705_CR25","doi-asserted-by":"crossref","unstructured":"Sookoian S, Fernandez MA, Castano G. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. World J Gastroenterol 2005;11(48):7560\u20137563","DOI":"10.3748\/wjg.v11.i48.7560"},{"key":"9705_CR26","doi-asserted-by":"crossref","unstructured":"Terui Y, Saito T, Watanabe H, et al. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology 2002;36(4 Pt 1):1022","DOI":"10.1053\/jhep.2002.32679"},{"key":"9705_CR27","doi-asserted-by":"crossref","unstructured":"Liu T, Wang X, Karsdal MA, Leeming DJ, Genovese F. Molecular serum markers of liver fibrosis. Biomark Insights 2012;7:105\u2013117","DOI":"10.4137\/BMI.S10009"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-016-9705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-016-9705-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-016-9705-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T21:19:01Z","timestamp":1567631941000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-016-9705-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9705"],"URL":"https:\/\/doi.org\/10.1007\/s12072-016-9705-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,22]]}}}